Institutional Ownership
Aspire Biopharma Hldgs Inc
CUSIP 738920206COMQ1 2026
Institutional Holders
11
13F filers
Shares Held
342.5K
Aggregate institutional
Institutional Value
$351.4K
Q1 2026
Net New Holders
+11
11 new · 0 closed
Institutional Ownership Trend
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradePosition Activity
Q1 2026
New positions11
Increased0
Decreased0
Sold out0
Institutional Holders
11 funds hold this security · Q1 2026
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Ubs Group AG | 191.5K | $197.2K | +191.5K | New |
| 2 | Morgan Stanley | 77.0K | $79.3K | +77.0K | New |
| 3 | Geode Capital Management, LLC | 43.4K | $44.7K | +43.4K | New |
| 4 | Crewe Advisors LLC | 20.3K | $20.9K | +20.3K | New |
| 5 | Toronto Dominion Bank | 5.0K | $5.2K | +5.0K | New |
| 6 | Tower Research Capital LLC (Trc) | 2.2K | $2.2K | +2.2K | New |
| 7 | Citigroup Inc | 1.8K | $1.9K | +1.8K | New |
| 8 | Osaic Holdings, Inc. | 2 | $2 | +2 | New |
| 9 | Avion Wealth | 1.4K | $1 | +1.4K | New |
| 10 | Sbi Securities Co., Ltd. | 1 | $1 | +1 | New |
1 more institutional holders on Premium
See every fund holding Aspire Biopharma Hldgs Inc, with full quarter-over-quarter share changes.
Unlock all holders